# EDGAR Filing Document

**Accession Number:** 0000888721
**File Stem:** 0001178913-25-003447
**Filing Date:** 2025-9
**Character Count:** 3871
**Document Hash:** 2eb9ab8ec0e7c8b29dcc13caddd80da4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-25-003447.hdr.sgml**: 20250930

**ACCESSION NUMBER**: 0001178913-25-003447

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20250930

**DATE AS OF CHANGE**: 20250930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TRINITY BIOTECH PLC
- **CENTRAL INDEX KEY:** 0000888721
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-22320
- **FILM NUMBER:** 251360313

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** IDA BUSINESS PARK
- **STREET 2:** BRAY
- **CITY:** WICKLOW
- **PROVINCE COUNTRY:** L2
- **BUSINESS PHONE:** 01135312955111

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** IDA BUSINESS PARK
- **STREET 2:** BRAY
- **CITY:** WICKLOW
- **PROVINCE COUNTRY:** L2

------

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

### F O R M 6-K

#### REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

#### UNDER THE SECURITIES EXCHANGE ACT OF 1934

#### For the month of September 2025

### TRINITY BIOTECH PLC
(Name of Registrant)

IDA Business Park

Bray, Co. Wicklow, Ireland

(Address of Principal Executive Office)

#### Indicate by check mark whether the registrant files or will file annual reports under cover of

#### Form 20-F or Form 40-F.

#### Form 20-F ☒ Form 40-F ☐

#### This Form 6-K is being incorporated by reference into our Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070).

------

#### Trinity Biotech plc Announces Results of Annual General Meeting
At the annual general meeting (the "Meeting") of the Company held on September 30 2025, shareholders approved all of the resolutions proposed by the requisite majorities and with a minimum approval of 93% of votes cast.

The resolutions (the text of which is more fully set out in the notice of meeting dated September 4 2025) were as follows:

&nbsp;&nbsp;&nbsp;&nbsp;1. To re-appoint Grant Thornton as statutory auditor of the Company to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company.

&nbsp;&nbsp;&nbsp;&nbsp;2. To authorise the board of directors to fix the statutory auditors' remuneration.

&nbsp;&nbsp;&nbsp;&nbsp;3. To reduce the nominal (par) value of each of the Company's A Ordinary Shares.

&nbsp;&nbsp;&nbsp;&nbsp;4. To increase the Company's authorised share capital.

&nbsp;&nbsp;&nbsp;&nbsp;5. To refresh the board of directors' authority to allot and issue new shares in the Company.

&nbsp;&nbsp;&nbsp;&nbsp;6. To refresh the board of directors' authority to allot and issue new shares for cash without applying Irish statutory pre-emption rights.

Jim Walsh retired by rotation from the Company's board of directors at the Meeting in accordance with the Company's constitution. The Company would like to express its sincere gratitude to Jim for his many contributions and his commitment over more than 30 years of service. The Company is also grateful that Jim has agreed to continue to support the Company's management team as a Scientific Advisor.

------

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| TRINITY BIOTECH PLC | TRINITY BIOTECH PLC |
|  | Trinity Biotech plc |
|  | (Registrant) |
| By: | /s/ Susan O'Connor |
|  | Susan O'Connor<br> Chief Financial Officer |

---

Date: September 30, 2025

------